Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
BioNTech enters CAR-T cell therapy collaboration with Autolus | The ...
Autolus - developing CAR T cell therapies for cancer patients
Autolus Therapeutics announces collaboration with Cabaletta Bio for use ...
Autolus Pockets A Massive €68M in Series C for CAR-T Cancer Therapies
Autolus CAR-T cell therapy gives hope for aggressive blood cancer ...
Autolus Competes in CAR-T Frenzy with FDA Approval of Aucatzyl
Autolus Therapeutics' CAR-T Cell Manufacturing Facility, Stevenage, UK
Autolus Therapeutics plc is Pioneering Programmed T cell Therapies
Autolus Reveals Early Clinical Data of Next-Gen CAR-T Therapy
Autolus - developing CAR T cell therapies for patients with cancer and ...
Information for patients | Autolus
Chimeric Antigen Receptor T Cell therapy | Innovation | Autolus
Autolus secures FDA approval for CAR-T cell therapy use in ALL ...
AGC Biologics to Manufacture LVV for Autolus Therapeutics’ AUCATZYL®
Autolus Therapeutics' T Cell Therapy: A Presentation Design Highlight ...
NIHR supports Autolus to advance next-generation CAR-T therapies | NIHR
Autolus Therapeutics: Pioneering CAR T-Cell Therapies in Autoimmune ...
BioNTech, Autolus enter strategic CAR-T cell therapy collaboration
Innovation | Autolus
Autolus Stock: Faces FDA Decision On CAR-T Therapy in November ...
Next-Generation CAR-T Firm Autolus Raises €130M on NASDAQ IPO
BioNTech and Autolus Join Forces to Accelerate CAR-T Cell Therapies ...
Our CAR T Focus | Autolus
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy ...
BioNTech partners with Autolus to advance CAR-T therapies
UK start-up Autolus starts ‘living medicine’ cancer trials | Financial ...
Autolus Therapeutics: Innovating T Cell Cancer Treatments (NASDAQ:AUTL ...
BioNTech's $200 Million Investment in Autolus Marks Milestone in ...
Syncona's Autolus and BioNTech forge alliance to propel CAR-T
Autolus Ltd., a UCLB spinout who develop programmed T-cell therapies ...
Autolus (AUTL) Selects Cardinal Health for Cell Therapy Supply
Autolus enters CAR-T race with FDA approval for Aucatzyl
BioNTech and Autolus collaborate for CAR T-cell therapies
CAR T Cell Therapy: Autolus Presents Data on AUT06NG
Autolus Therapeutics announces FDA approval of Aucatzyl | The Pharmaletter
Autolus reports data from trial of TRBC1-targeting cell therapy
Autolus Therapeutics: The Story Has Improved (NASDAQ:AUTL) | Seeking Alpha
Autolus will apply the capital to its CAR T-cell therapy currently ...
Autolus Raises $220 Million as it Reports Positive Interim Data from ...
BioNTech, Autolus make wide-ranging licensing, manufacturing deal for ...
Autolus Launches Roadshow for Initial Public Offering | Business Wire
Pipeline products | Innovation | Autolus
Leadership | About us | Autolus
Autolus Therapeutics announces a publication in Nature Medicine on obe ...
Autolus (AUTL): Pivotal Trial Using Familiar Approach, Possible ...
BioNTech and Autolus Collaborate on CAR-T Cell Therapy
Autolus Therapeutics files BLA for new CAR T cell therapy | Ijlal Syed ...
About us | Autolus
Autolus Therapeutics To Present Three Clinical Data Updates On ...
Autolus Therapeutics (NASDAQ:AUTL) Given New $6.00 Price Target at ...
Autolus - Drug Discovery World (DDW)
Autolus Therapeutics Could Hold A Winning CAR T-Cell Ticket (NASDAQ ...
Autolus Receives Positive EU Recommendation for Blood Cancer Cell ...
Chart of the Day: Autolus Therapeutics - Effective Cancer Treatments ...
Autolus Therapeutics Announces License of AUCATZYL® (obecabtagene ...
Autolus Therapeutics Announces FDA Approval of AUCATZYL®
Autolus Therapeutics Announces FDA Approval of AUCATZYL® (obecabtagene ...
Autolus Therapeutics Announces Board Changes | citybiz
Autolus's 2023 T Cell Therapy Innovations: A Presentation Design ...
Autolus创新CAR-T疗法obe-cel向FDA递交上市申请，治疗B-ALL
Merit to build UK's first CAR-T cell manufacturing facility in ...
What is CAR-T? The technology behind Autolus’ cancer hope - 25 - 04 ...
AUCATZYL CAR T Therapy Wins EU Approval for Adult Leukemia Treatment ...
3个月完全缓解！完全缓解率63%！新型CAR-T疗法Aucatzyl获FDA批准_患者_治疗_普基仑
Top 10 Biotech Companies in London | HealthTech Leaders
Variety of Connections, Unlimited Licensing Aid Cancer Therapy ...
Autolus: CAR-T Therapy Looks Promising (NASDAQ:AUTL) | Seeking Alpha
CAR T-cell therapy in autoimmune diseases - The Lancet
A Review of CAR T-Cell Therapies Approved for the Treatment of Relapsed ...
Frontiers | Charting new paradigms for CAR-T cell therapy beyond ...
CAR T Cell Therapy: A Versatile Living Drug
Autolu：CD19 CAR-T细胞疗法提交上市申请医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
CAR-T/TCR-T细胞治疗专区 - 生物谷
CAR T-Cell Therapy Infographic - National Cancer Institute
Autolus: MHRA approves commercial CAR-T plant
UK biotech takes on personalised cancer therapy side effects
Strong growth for Merit
Frontiers | Challenges and innovations in CAR-T cell therapy: a ...
Frontiers | CAR-T cell therapy for hematological malignancies ...
Autolus: CAR-терапия следующего поколения против рака | МОСМЕДПРЕПАРАТЫ
Luminary Group on LinkedIn: Updated: FDA approves Autolus’ CAR-T cell ...
FDA approves new CAR-T competitor to Gilead’s Tecartus Aucatzyl ...
Key Investigational CAR-T Cell Therapies for MM | Download Scientific ...
Portfolio | Syncona
NICE backs NHS use of Autolus' leukaemia CAR-T | pharmaphorum
How can the UK can improve in clinical research? A biotech perspective
01126-1/asset/953d0d8a-28a2-4c22-a384-91d2ef3527e0/main.assets/gr2_lrg.jpg)
